Xiaoyang Ai

Dr. Xiaoyang Ai


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Gels
Verified
Journal Article
Open access
PDF file
AAAwn Abbas
Awn Abbas
LNLi Nanxin
Li Nanxin
SNSameera Naseer
Sameera Naseer
LCLian Chen
Lian Chen
XAXiaoyang Ai
Xiaoyang Ai
HFHualin Fu
Hualin Fu
Gelatin methacrylate (GelMA) hydrogels are promising carriers for bioactive agents like curcumin (Cur) and adenosine diphosphate (ADP) in wound healing. However, existing GelMA-based systems fail to achieve both rapid hemostasis and sustained anti-inflammatory effects. In this study, we developed a Cur/ADP GelMA hydrogel, and evaluated its anti-inflammatory, regenerative, hemostatic, and biocompatible properties. Proton nuclear magnetic resonance (1H-NMR) analysis showed that a 65% degree of substitution of GelMA is optimal for wound dressings. Scanning electron microscopy revealed a uniform pore size, aiding inflammatory exudate removal. The Cur/ADP GelMA hydrogel exhibited strong adhesion, stability, and antibacterial activity, reducing E. coli and S. aureus proliferation by 85% and 72%, respectively. Hemostatic effects were observed, with blood loss reduced to 238 ± 23 mg compared to 559 ± 18 mg in the untreated group. The ELISA results showed reduced pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and increased IL-10. In vivo studies demonstrated 98% wound closure by day 14, enhanced granulation tissue formation, and a 70% thicker epidermis compared to controls. Mechanistically, ADP accelerates platelet activation and clot formation, while Cur modulates the inflammatory microenvironment, enabling synergistic hemostasis and immune regulation, thus promoting accelerated wound healing.

Verified
Journal Article
Open access
PDF file
LNLi Nanxin
Li Nanxin
CLChao Li
Chao Li
DLDongbo Li
Dongbo Li
AAAwn Abbas
Awn Abbas
XCXingyu Chen
Xingyu Chen
HFHualin Fu
Hualin Fu
Wound infections remain significant challenges for current tissue adhesives, primarily due to their poor adhesion in moist environments, slow bonding, cytotoxicity, and limited antibacterial properties. Slightly acidic electrolyzed water (SAEW), a potent disinfectant, suffers from limited stability due to chlorine loss. This study developed a novel SAEW-based hydrogel (SAEW-gel) by combining SAEW with chitosan and β-glycerol disodium phosphate to improve its stability and therapeutic potential. SAEW-gel demonstrated high water absorption, long-term water retention, and enhanced antibacterial activity against S. aureus and E. coli compared to SAEW alone. It maintained germicidal efficacy after prolonged storage and significantly accelerated wound healing in a rat model, achieving a 95.41% healing rate by the 12th day of treatment. Mechanistically, SAEW-gel reduced inflammatory cell infiltration, promoted granulation and collagen formation, and regulated inflammatory markers (IL-6, IL-1β, TNF-α, MPO, HYP). These findings highlight SAEW-gel as a promising biomaterial for treating infectious wounds and support its potential for future clinical application.

23 December 2024 in Gels
Verified
Journal Article
Open access
PDF file
DLDongbo Li
Dongbo Li
AAAwn Abbas
Awn Abbas
NLNanxin Li
Nanxin Li
CLChao Li
Chao Li
XAXiaoyang Ai
Xiaoyang Ai
HFHualin Fu
Hualin Fu
Altrenogest is a key regulatory hormone for intensive and batch management of reserve sows in breeding farms. As a synthetic hormone, altrenogest could make ovaries stay at the initial stage of follicles and inhibit estrus and ovulation in animals. However, the currently used oral altrenogest solution needs to be administered continuously every day for more than two weeks in clinical practice. In this study we developed a phospholipid-based injectable gel carrying altrenogest to decrease the number of administrations, sustain release of the drug, and enhance therapeutic efficacy for clinical use. The altrenogest gel had a viscosity of 100 cP before phase transition and over 1,000,000 cP after phase transition. In vitro, altrenogest can be continuously released from gel for over two weeks. The pharmacokinetic results showed that the AUC (0–∞) of the altrenogest gel was almost double that of the altrenogest solution. The MRT (0–∞) was 40.92 ± 7.21 h and the t1/2 of the altrenogest gel was 80.03 ± 20.79 h. The altrenogest gel demonstrated excellent fluidity, ease of injectability, high drug-loading capacity, and appropriate sustained-release characteristics both in vitro and in vivo, making it a potential drug delivery system for swine production.

9 September 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
GLGuopan Li
Guopan Li
SGSirong Gao
Sirong Gao
XAXiaoyang Ai
Xiaoyang Ai
JRJun Rong
Jun Rong
DCDisi Chen
Disi Chen
WGWeiwei Guo
Weiwei Guo
Fowl adenovirus serotype 11 (FAdV-11) is an emerging pathogen associated with inclusion body hepatitis (IBH) and high mortality in commercial broilers. In this study, we evaluated the protective efficacy of maternal antibody transfer against FAdV-11 in neonatal chicks. A hypervirulent FAdV-11 strain (FAdV-11/HB2022/1), isolated from an IBH outbreak in Hubei Province, China, caused 90% mortality in 1-day-old specific-pathogen-free (SPF) chickens; 7-day-old chicks exhibited no mortality but developed mild hepatic lesions and sustained viral replication. A soluble, trimeric Fiber subunit vaccine (Fiber282–569) was developed through rational truncation of the transmembrane domain, retaining both the shaft and head domains, with its homotrimeric conformation confirmed by size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS). Immunization of breeder hens with Fiber282–569 elicited high titers of FAdV-11-specific IgY and neutralizing antibodies that were efficiently transferred to progeny via the egg yolk. Upon lethal challenge with FAdV-11/HB2022/1, 1-day-old progeny chicks from vaccinated breeders exhibited 100% survival with no clinical signs, no gross pathological lesions, and undetectable viral loads in liver tissues, demonstrating complete protection. In contrast, all chicks from unvaccinated breeders succumbed within 5 days post-infection. These results demonstrate that maternal antibody transfer of the fiber-based subunit vaccine confers complete protection against lethal FAdV-11 infection in neonatal chicks, providing a safe and effective candidate strategy for controlling FAdV-11 in the poultry industry.

21 October 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YCYixing Chen
Yixing Chen
JLJing Li
Jing Li
LNLi Nanxin
Li Nanxin
AAAwn Abbas
Awn Abbas
XAXiaoyang Ai
Xiaoyang Ai
HFHualin Fu
Hualin Fu
Background: Altrenogest (ALT) is a synthetic progestogen used to synchronize the oestrus of swine and horses. It is poorly absorbed orally and this severely limits its use. Self-nanoemulsifying drug delivery systems (SNEDDSs) have been identified as a potentially efficacious solution to these challenges, as they spontaneously generate fine oil-in-water nanoemulsions upon exposure to gastrointestinal fluids, thereby augmenting the dissolution and bioavailability of lipophilic drugs. Objective: In order to enhance the oral bioavailability of ALT, this study developed an ALT-loaded SNEDDS. The mechanisms of cellular uptake were investigated using MDCK monolayers, while in vivo pharmacokinetics and in situ intestinal perfusion studies in rats were conducted to assess systemic absorption, lymphatic transport potential, and intestinal permeation. Methods & Results: In vitro, ALT-SNEDDS demonstrated no significant toxicity towards MDCK cells at concentrations up to 12.8 μg/mL. The uptake of ALT-SNEDDS was found to be time- and energy-dependent, involving clathrin- and caveolae-mediated endocytosis. In rats, ALT-SNEDDS and its hydrated form, in comparison with an oil-based formulation, resulted in a significant elevation of Cmax and AUC, yielding 1.96- and 4.97-fold improvements in oral bioavailability. Lymphatic involvement was supported by a significant decrease in plasma concentration following cycloheximide blockade. Intestinal perfusion showed significantly higher Ka and Peff values for ALT-SNEDDS than free ALT, confirming enhanced small intestinal absorption. In an acute oral toxicity study, a single 40 mg/kg oral dose caused no apparent histopathological abnormalities in the major organs of rats. Conclusion: Collectively, the SNEDDS platform markedly facilitates ALT absorption and exhibits lymphatic transport propensity, providing a foundation for subsequent formulation optimization and for evaluation in the target species.